TP73 and cancer: Here, we have just-in-time produced the canonical p73 protein and two aberrantly overexpressed ∆Np73 isoforms, frequently upregulated in cancer, using a cell-free system for its direct use to determine the presence of specific autoantibodies against them (Fig. 1).